Close Menu

In Nature this week, research led by Novartis' Feng Cong identified a new molecule in the Wnt signaling pathway that could potentially be a target in Wnt-dependent cancers. Using a chemical genetic screen, the scientists found that XAV939, a small molecule that selectively inhibits beta-catenin-mediated transcription, effectively stabilizes axin.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.